1. Greenlee R, Murray T, Bolden S, et al. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7-33. 2. Meyer T, Merkel S, Goehl J, et al. Surgical therapy for distant metastases of malignant melanoma. American Cancer Society. 2000;98:1983-1991. 3. Rigel D. Malignant melanoma: perspectives on incidence and its effects on awareness, diagnosis, and treatment. CA Cancer J Clin. 1996;46:195-198. 4. Parker S, Tong T, Bolden S, et al. Cancer statistics, 1997. CA Cancer J Clin. 1997;47:5-17. 5. Hieken T, Ronan S, Farolan M, et al. Molecular prognostic markers in intermediate-thickness cutaneous malignant melanoma. Cancer. 1999;85:375-382. 6. Woessner JJ. Matrix metalloproteinases and their inhibitors in connective tissues remodeling. FASEB J. 1991;5:2145-2179. 7. Matrisian L. The matrix degrading metalloproteinases. BioEssays. 1992;14:455-463. 8. Kahari V, Saarialho-Kere U. Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med. 1999;31:34-45. 9. Johansson N, Ahonen M, Kahari V. Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci. 2000;57:5-15. 10. Freije J, Diez-Itza I, Baldin M, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem. 1994;269:16766-16773. 11. Knauper V, Will H, Lopez-Otin C, et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem. 1996;271:1544-1550. 12. Johansson N, Saarialho-Kere U, Airola K, et al. Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev Dyn. 1997 Mar;208(3):387-97. 1997;208:387-397. 13. Stahle-Backdahl M, Sandstedt B, Bruce K, et al. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab Invest. 1997;76:717-728. 14. Vaalamo M, Karjalainen-Lindsberg M, Puolakkainen P, et al. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am J Pathol. 1998;152:1005-1014. 15. Uitto V, Airola K, Vaalamo M, et al. Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation. Am J Pathol. 1998 Jun;152(6):1489-99. 1998;152:1486-1499. 16. Mitchell P, Magna H, Reeves L, et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest. 1996;97:761-768. 17. Wernicke D, Seyfert C, Hinzmann B, et al. Cloning of collagenase 3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis. J Rheumatol. 1996;23:590-595. 18. Johansson N, Airola K, Grenman R, et al. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol. 1997;151:499-508. 19. Johansson N, Vaalamo M, Grenman S, et al. Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am J Pathol. 1999;154:469-480. 20. Scully S, Berend K, Qi W, et al. Collagenase specificity in chondrosarcoma metastasis. Braz J Med Biol Res. 1999 Jul;32(7):885-9. 1999;32:885-889. 21. Uria J, Balbin M, Lopez J, et al. Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. Am J Pathol. 1998;153:91-101. 22. Airola K, Johansson N, Kariniemi A, et al. Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J Invest Dermatol. 1997 Aug;109(2):225-31. 1997;109:225-231. 23. Bostrom P, Ravanti L, Reunanen N, et al. Expression of collagenase-3 (matrix metalloproteinase-13) in transitional-cell carcinoma of the urinary bladder. Int J Cancer. 2000;88:417-423. 24. Brinckerhoff C, Rutter J, Benbow U. Interstitial collagenases as markers of tumor progression. Clin Cancer Res. 2000;6:4823-4830. 25. Airola K, Karonen T, Vaalamo M, et al. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br J Cancer. 1999;80:733-743. 26. Thompson J. The revised American Joint Committee on Cancer staging system for melanoma. Semin Oncol. 2002;29:361-369.
|